vs
Side-by-side financial comparison of AbbVie (ABBV) and Intel (INTC). Click either name above to swap in a different company.
AbbVie is the larger business by last-quarter revenue ($15.0B vs $13.6B, roughly 1.1× Intel). AbbVie runs the higher net margin — 4.6% vs -31.5%, a 36.2% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (9.9% vs 7.0%). Over the past eight quarters, Intel's revenue compounded faster (2.9% CAGR vs 1.8%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Intel Corporation is an American multinational technology company headquartered in Santa Clara, California. It designs, manufactures, and sells computer components such as central processing units (CPUs) and related products for business and consumer markets. Intel was the world's third-largest semiconductor chip manufacturer by revenue in 2024 and has been included in the Fortune 500 list of the largest United States corporations by revenue since 2007.
ABBV vs INTC — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $15.0B | $13.6B |
| Net Profit | $697.0M | $-4.3B |
| Gross Margin | — | 39.4% |
| Operating Margin | 26.6% | — |
| Net Margin | 4.6% | -31.5% |
| Revenue YoY | 9.9% | 7.0% |
| Net Profit YoY | -46.0% | -354.1% |
| EPS (diluted) | $0.39 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $15.0B | $13.6B | ||
| Q4 25 | $16.6B | $13.7B | ||
| Q3 25 | $15.8B | $13.7B | ||
| Q2 25 | $15.4B | $12.9B | ||
| Q1 25 | $13.3B | $12.7B | ||
| Q4 24 | $15.1B | $14.3B | ||
| Q3 24 | $14.5B | $13.3B | ||
| Q2 24 | $14.5B | $12.8B |
| Q1 26 | $697.0M | $-4.3B | ||
| Q4 25 | $1.8B | $-591.0M | ||
| Q3 25 | $186.0M | $4.1B | ||
| Q2 25 | $938.0M | $-2.9B | ||
| Q1 25 | $1.3B | $-821.0M | ||
| Q4 24 | $-22.0M | $-126.0M | ||
| Q3 24 | $1.6B | $-16.6B | ||
| Q2 24 | $1.4B | $-1.6B |
| Q1 26 | — | 39.4% | ||
| Q4 25 | 72.6% | 36.1% | ||
| Q3 25 | 66.4% | 38.2% | ||
| Q2 25 | 71.8% | 27.5% | ||
| Q1 25 | 70.0% | 36.9% | ||
| Q4 24 | 70.9% | 39.2% | ||
| Q3 24 | 70.9% | 15.0% | ||
| Q2 24 | 70.9% | 35.4% |
| Q1 26 | 26.6% | — | ||
| Q4 25 | 27.3% | 4.2% | ||
| Q3 25 | 12.1% | 5.0% | ||
| Q2 25 | 31.7% | -24.7% | ||
| Q1 25 | 28.0% | -2.4% | ||
| Q4 24 | -9.9% | 2.9% | ||
| Q3 24 | 26.5% | -68.2% | ||
| Q2 24 | 27.6% | -15.3% |
| Q1 26 | 4.6% | -31.5% | ||
| Q4 25 | 10.9% | -4.3% | ||
| Q3 25 | 1.2% | 29.8% | ||
| Q2 25 | 6.1% | -22.7% | ||
| Q1 25 | 9.6% | -6.5% | ||
| Q4 24 | -0.1% | -0.9% | ||
| Q3 24 | 10.8% | -125.3% | ||
| Q2 24 | 9.5% | -12.5% |
| Q1 26 | $0.39 | $-0.73 | ||
| Q4 25 | $1.02 | $-0.10 | ||
| Q3 25 | $0.10 | $0.90 | ||
| Q2 25 | $0.52 | $-0.67 | ||
| Q1 25 | $0.72 | $-0.19 | ||
| Q4 24 | $-0.03 | $-0.03 | ||
| Q3 24 | $0.88 | $-3.88 | ||
| Q2 24 | $0.77 | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $32.8B |
| Total DebtLower is stronger | — | $2.0B |
| Stockholders' EquityBook value | — | $125.0B |
| Total Assets | — | $205.3B |
| Debt / EquityLower = less leverage | — | 0.02× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $32.8B | ||
| Q4 25 | $5.3B | $14.3B | ||
| Q3 25 | $5.7B | $11.1B | ||
| Q2 25 | $6.5B | $9.6B | ||
| Q1 25 | $5.2B | — | ||
| Q4 24 | $5.6B | $8.2B | ||
| Q3 24 | $7.3B | — | ||
| Q2 24 | $13.2B | — |
| Q1 26 | — | $2.0B | ||
| Q4 25 | $58.9B | $46.6B | ||
| Q3 25 | $63.0B | — | ||
| Q2 25 | $63.0B | — | ||
| Q1 25 | $64.5B | — | ||
| Q4 24 | $60.3B | $50.0B | ||
| Q3 24 | $58.5B | — | ||
| Q2 24 | $58.0B | — |
| Q1 26 | — | $125.0B | ||
| Q4 25 | $-3.3B | $114.3B | ||
| Q3 25 | $-2.6B | $106.4B | ||
| Q2 25 | $-183.0M | $97.9B | ||
| Q1 25 | $1.4B | $99.8B | ||
| Q4 24 | $3.3B | $99.3B | ||
| Q3 24 | $6.0B | $99.5B | ||
| Q2 24 | $6.8B | $115.2B |
| Q1 26 | — | $205.3B | ||
| Q4 25 | $134.0B | $211.4B | ||
| Q3 25 | $133.9B | $204.5B | ||
| Q2 25 | $137.2B | $192.5B | ||
| Q1 25 | $136.2B | $192.2B | ||
| Q4 24 | $135.2B | $196.5B | ||
| Q3 24 | $143.4B | $193.5B | ||
| Q2 24 | $141.9B | $206.2B |
| Q1 26 | — | 0.02× | ||
| Q4 25 | — | 0.41× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 45.44× | — | ||
| Q4 24 | 18.15× | 0.50× | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | 8.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABBV
Segment breakdown not available.
INTC
| Client Computing Group (CCG) | $7.7B | 57% |
| Intel Foundry | $5.4B | 40% |
| All other | $600.0M | 4% |
